Markers for pathologic cardiac hypertrophy (Anp), fibrosis (Col1a1, Col3a1, and Galectin-3), and inflammation (Cox2 and Tnf-α) were also assessed (Figure 6A–L). This evidence concerns the gene COL1A1 and cardiac hypertrophy.